IA
Icon Advisers’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-31,229
| Closed | -$4.24M | – | 307 |
|
|
2018
Q4 | $4.24M | Sell |
31,229
-751
| -2% | -$102K | 0.45% | 68 |
|
|
2018
Q3 | $8.78M | Sell |
31,980
-8,579
| -21% | -$2.35M | 0.74% | 40 |
|
|
2018
Q2 | $8.4M | Hold |
40,559
| – | – | 0.64% | 52 |
|
|
2018
Q1 | $6.7M | Buy |
40,559
+21,484
| +113% | +$3.55M | 0.51% | 64 |
|
|
2017
Q4 | $2.61M | Hold |
19,075
| – | – | 0.18% | 127 |
|
|
2017
Q3 | $2.6M | Hold |
19,075
| – | – | 0.18% | 154 |
|
|
2017
Q2 | $2.32M | Hold |
19,075
| – | – | 0.16% | 185 |
|
|
2017
Q1 | $2.02M | Buy |
19,075
+11,500
| +152% | +$1.22M | 0.14% | 194 |
|
|
2016
Q4 | $770K | Hold |
7,575
| – | – | 0.05% | 306 |
|
|
2016
Q3 | $773K | Buy |
7,575
+5,500
| +265% | +$561K | 0.05% | 331 |
|
|
2016
Q2 | $247K | Hold |
2,075
| – | – | 0.02% | 359 |
|
|
2016
Q1 | $222K | Sell |
2,075
-900
| -30% | -$96.3K | 0.02% | 328 |
|
|
2015
Q4 | $323K | Sell |
2,975
-15,600
| -84% | -$1.69M | 0.02% | 332 |
|
|
2015
Q3 | $1.59M | Sell |
18,575
-10,156
| -35% | -$870K | 0.11% | 174 |
|
|
2015
Q2 | $2.9M | Sell |
28,731
-4,800
| -14% | -$484K | 0.18% | 131 |
|
|
2015
Q1 | $2.59M | Sell |
33,531
-28,000
| -46% | -$2.16M | 0.15% | 135 |
|
|
2014
Q4 | $3.27M | Buy |
61,531
+30,900
| +101% | +$1.64M | 0.19% | 124 |
|
|
2014
Q3 | $1.44M | Buy |
30,631
+9,000
| +42% | +$423K | 0.08% | 179 |
|
|
2014
Q2 | $1.35M | Buy |
+21,631
| New | +$1.35M | 0.08% | 184 |
|
|
2014
Q1 | – | Sell |
-5,000
| Closed | -$263K | – | 335 |
|
|
2013
Q4 | $263K | Buy |
+5,000
| New | +$263K | 0.02% | 264 |
|